Proopiomelanocortin processing in corticotroph cells is known to be operated by
prohormone convertase (PC) 1/3 which is activating several pro-
proteins and prohormones by intracellular limited proteolysis processing. In this study, we hypothesized that PC1/3 expression differs between
Cushing's disease (CD) and silent
corticotroph adenoma (SCA), and investigated whether PC1/3 expression is involved in the
adrenocorticotropin (
ACTH) silence of SCA. We performed immunohistochemical analysis of
pituitary adenoma specimens for six adenohypophysial
hormones, PC1/3 and
chromogranin A (CgA). Subjects for this study consisted of 12 anterior
pituitary adenomas of CD (1 male, 11 female; 14-70 years old) and 31 non-functioning
adenomas (23 male, 8 female; 32-71 years old).
ACTH immunoreactivity was observed in all of CD and three of 31 non-functioning
adenomas. The three cases diagnosed as SCA were also positive for
growth hormone and
follicle-stimulating hormone. Cushing's
adenomas and SCAs were all positive for PC1/3. PC1/3-positive cells did not always colocalize with
ACTH but some of them colocalized with CgA in SCAs. Even if PC1/3 is not present in corticotroph cells, PC1/3 immunoreactivity in SCA may originate from CgA-positive cells. We conclude that immunohistochemistry for PC1/3 is not helpful for differential diagnosis between CD and SCA in clinical practice, though the regulation of PC1/3 expression is likely to be an important etiological factor in
ACTH silence of SCA. The diversity of immunohistochemical properties of SCA leads us to speculate that it is not a single entity and may be a general diagnostic term for
adenomas of varying etiology.